Introduction
In the era of precision medicine, the role of genetic testing and screening have become pivotal in identifying inherited disorders, predicting disease risk, and enabling preventive healthcare strategies. While these terms are often used interchangeably, they serve different purposes in clinical and research settings. Understanding the difference between genetic testing and genetic screening is crucial for healthcare providers, patients, and researchers alike 1, 2.
This blog aims to clarify the distinction between genetic testing and screening, offering detailed insights into their definitions, applications, and significance in modern medicine.
What is Genetic Testing?
Genetic testing refers to the process of analysing an individual’s DNA, RNA, chromosomes, or proteins to detect specific genetic variants. It is typically performed when there is a clinical indication, such as a family history of a genetic disorder or the presence of symptoms suggesting a genetic condition 1, 3, 4.
The primary goals of genetic testing include:
- Diagnosing genetic diseases
- Predicting disease risk
- Guiding treatment decisions
- Identifying carriers of hereditary conditions
- Confirming prenatal or newborn screening results 1, 3, 4
There are several types of genetic testing, including:
- Diagnostic testing: Used to rule out or confirm a suspected genetic disorder 1, 4.
- Prenatal testing: Used to identify genetic or chromosomal abnormalities in a developing fetus. It is typically recommended for couples who are at a higher risk of passing on inherited conditions based on screening tests. or family history. The testing involves collecting fetal tissue samples, which can be obtained through procedures like amniocentesis or chorionic villus sampling 1, 4.
- Pharmacogenetic testing: Determines how an individual’s genetic makeup affects their response to medication1, 4.
- Preimplantation testing/Preimplantation genetic diagnosis (PGD): Used during in vitro fertilisation (IVF) to examine embryos for genetic defects. Only embryos that do not carry significant genetic variants are selected and transferred to the uterus to increase the likelihood of a healthy pregnancy 1, 4.
What is Genetic Screening?
Genetic screening, on the other hand, is a broader and more population-focused approach. It is designed to identify individuals in a group who are at an increased risk of a genetic disorder, even if they have no symptoms or family history. Unlike genetic testing, which is usually diagnostic or confirmatory, genetic screening is preventive 5, 6.
The primary objectives of genetic screening include:
- Early detection of disease risk
- Identification of carriers in a population
- Prevention of genetic disorders through informed reproductive choices
- Public health surveillance 1, 5, 6
Examples of genetic screening programs include:
- Predictive/presymptomatic/predispositional testing: Used to detect whether an individual is at an increased risk of developing a disease before any symptoms appear. It can reveal genetic mutations linked to a higher likelihood of developing inherited diseases, including cancer 1, 4.
- Newborn screening: Carried out on infants shortly after birth to evaluate the potential risk for certain genetic disorders. This testing often measures protein and enzyme levels, which can be altered in babies affected by these conditions 1, 4, 6.
- Carrier screening: Recommended for individuals or couples planning a pregnancy, particularly in populations with a high prevalence of certain genetic disorders. It helps in identifying individuals who carry a gene for a recessive disorder, like cystic fibrosis or Tay-Sachs disease 1, 4, 6.
- Noninvasive prenatal testing or screening (NIPT/NIPS): Conducted during pregnancy to assess the risk or likelihood that a fetus may have specific genetic conditions, including chromosomal disorders like Down syndrome 1, 4, 6.
Genetic Testing vs Genetic Screening
Understanding the difference between genetic testing and genetic screening is essential for implementing appropriate healthcare interventions. Though both involve genetic analysis, they differ in purpose, methodology, and context.
The key differences between genetic testing vs genetic screening are mentioned below:
| Aspect |
Genetic Screening |
Genetic Diagnostic Testing |
| Purpose |
Estimates the risk of a genetic condition in asymptomatic individuals |
Rules out or confirms a suspected genetic condition in symptomatic individuals |
| Target Group |
People without symptoms, generally at-risk populations |
Individuals with symptoms or a known family history of a genetic disorder |
| Test Result Interpretation |
Indicates whether risk is higher or lower than average |
Provides a definitive result regarding the presence or absence of a specific genetic condition |
| Result Types |
Risk estimate; may yield false positives or false negatives |
Conclusive (positive or negative for a specific mutation or condition) |
| Follow-up |
May require additional diagnostic testing for confirmation |
Can guide medical decisions, treatment plans, and family planning |
| Application in Reproductive Planning |
Helps identify potential genetic risks before conception or during pregnancy |
Can be done prenatally or at any life stage to confirm genetic conditions |
| Availability |
Often available as routine population-based programs (e.g., newborn screening) |
Limited to conditions with known and testable genetic markers |
| Examples |
Newborn screening, carrier screening, NIPT |
Testing for BRCA1/BRCA2 mutations, Pharmacogenetic testing |
Both genetic testing and screening are valuable tools in genomics, but their roles are not interchangeable. Screening is usually the first step in identifying potential genetic risk whereas genetic testing confirms and elaborates on these risks 1, 4, 6.
Conclusion
The difference between genetic testing and genetic screening lies in their purpose, scope, and application. While genetic screening serves as a preliminary tool to identify at-risk individuals in a population, genetic testing provides definitive answers for specific genetic concerns. Both play crucial roles in early diagnosis, prevention, and personalised treatment strategies.
As the field of genomics advances, understanding the aspects of genetic testing and screening becomes increasingly important for healthcare professionals and patients. Effective integration of both tools, guided by scientific evidence and ethical frameworks, can transform healthcare delivery and improve patient outcomes.
In summary, recognising the difference between genetic testing and genetic screening not only enhances clinical decision-making but also empowers individuals with knowledge about their genetic health.
MedGenome plays a significant role in advancing both genetic testing and screening. It offers a wide range of genomic solutions, including diagnostic genetic tests for inherited diseases, cancer genomics, and reproductive health. MedGenome’s services aid in early disease detection, risk assessment, and personalised treatment planning. In addition to genetic testing, MedGenome provides genetic counselling to help patients and families understand test results, assess hereditary risks, and make informed healthcare or reproductive decisions 7, 8.
References:
- page title. (2025, March 14). MedGenome – Leading Genetics Diagnostics Lab in India – MedGenome – Leading Genetics Diagnostics Lab in India. https://diagnostics.medgenome.com/
